Effectiveness of the sirolimus-eluting stent in the treatment of patients with a prior history of coronary artery bypass graft surgery

Coronary Artery Disease

Volumn 15, Issue 3, 2004, Pages 171-175

  Hoye, Angela ^a   Lemos, Pedro A ^a   Arampatzis, Chourmouzios A ^a   Saia, Francesco ^a   Tanabe, Kengo ^a   Degertekin, Muzaffer ^a   Hofma, Sjoerd ^a   McFadden, Eugene ^a   Sianos, Georgios ^a   Smits, Pieter C ^a   Van Der Giessen, Willem J ^a   De Feyter, Pim ^a   Van Domburg, Ron T ^a   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Angioplasty; Atherosclerosis; Bypass; Coronary artery disease; Drugs; Restenosis

Indexed keywords

RAPAMYCIN;

ADULT; AGED; ANAMNESIS; ARTICLE; ATHEROSCLEROSIS; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; FEMALE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; NETHERLANDS; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 2342469342     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200405000-00006     Document Type: Article

References (28)

1. Campeau L, Enjalbert M, Lesperance J, Vaislic C, Grondin CM, Bourassa MG. Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at two weeks, one year, 5-7 years, and 10-12 years after surgery. Circulation 1983; 68:II1-II7.
2. FitzGibbon GM, Leach AJ, Kafka HP, Keon WJ. Coronary bypass graft fate: long-term angiographic study. J Am Coll Cardiol 1991; 17:1075-1080.
3. Kroncke GM, Kosolcharoen P, Clayman JA, Peduzzi PN, Detre K, Takaro T. Five-year changes in coronary arteries of medical and surgical patients of the Veterans Administration Randomised Study of Bypass Surgery. Circulation 1988; 78:I144-I150.
4. Hwang MH, Meadows WR, Palac RT, Piao ZE, Pifarre R, Loeb HS, et al. Progression of native coronary artery disease at 10 years: insights from a randomised study of medical versus surgical therapy for angina. J Am Coll Cardiol 1990; 16:1066-1070.
5. Cameron AA, Davis KB, Rogers WJ. Recurrence of angina after coronary artery bypass surgery: predictors and prognosis (CASS Registry). Coronary Artery Surgery Study. J Am Coll Cardiol 1995; 26:895-899.
6. Foster ED. Re-operation for coronary artery disease. Circulation 1985; 72:V59-V64.
7. Loop FD. A 20-year experience in coronary artery re-operation. Eur Heart J 1989; 10 (Suppl H):78-84.
8. Bourassa MG, Detre KM, Johnston JM, Vlachos HA, Holubkov R. Effect of prior revascularisation on outcome following percutaneous coronary intervention: NHLBI Dynamic Registry. Eur Heart J 2002; 23:1546-1555.
9. Garzon P, Sheppard R, Eisenberg MJ, Schechter D, Lefkovits J, Goudreau E, et al. Comparison of event and procedure rates following percutaneous transluminal coronary angioplasty in patients with and without previous coronary artery bypass graft surgery (the ROSETTA [Routine versus Selective Exercise Treadmill Testing after Angioplasty] Registry). Am J Cardiol 2002; 89:251-256.
10. Mathew V, Berger PB, Lennon RJ, Gersh BJ, Holmes DR, Jr. Comparison of percutaneous interventions for unstable angina pectoris in patients with and without previous coronary artery bypass grafting. Am J Cardiol 2000; 86:931-937.
11. Kleiman NS, Anderson HV, Rogers WJ, Theroux P, Thompson B, Stone PH. Comparison of outcome of patients with unstable angina and non-Q-wave acute myocardial infarction with and without prior coronary artery bypass grafting. (Thrombolysis in Myocardial Ischemia III Registry). Am J Cardiol 1996; 77:227-231.
12. Al Suwaidi J, Velianou JL, Berger PB, Mathew V, Garratt KN, Reeder GS, et al. Primary percutaneous coronary interventions in patients with acute myocardial infarction and prior coronary artery bypass grafting. Am Heart J 2001; 142:452-459.
13. Stone GW, Brodie BR, Griffin JJ, Grines L, Boura J, O'Neill WW, et al. Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infarction. Second Primary Angioplasty in Myocardial Infarction Trial (PAMI-2) Investigators. J Am Coll Cardiol 2000; 35:605-611.
14. de Jaegere PP, van Domburg RT, Feyter PJ, Ruygrok PN, van der Giessen WJ, van den Brand MJ, et al. Long-term clinical outcome after stent implantation in saphenous vein grafts. J Am Coll Cardiol 1996; 28:89-96.
15. Savage MP, Douglas JS, Jr., Fischman DL, Pepine CJ, King SB, 3rd, Werner JA, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. N Engl J Med 1997; 337:740-747.
16. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomised comparison of a sirolimus-eluting stent with a standard stent for coronary revascularisation. N Engl J Med 2002; 346:1773-1780.
17. Sousa JE, Costa MA, Sousa AG, Abizaid AC, Seixas AC, Abizaid AS, et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 2003; 107:381-383.
18. Lemos P, Degertekin M, Saia F, Tanabe K, Arampatzis CA, Hoye A, et al. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes - insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. J Am Coll Cardiol 2003; 41:2093-2099.
19. Lemos P, van Domburg RT, Saia F, Arampatzis C, Hoye A, Degertekin M, et al. Unrestricted Utilization of Sirolimus-Eluting Stents Compared to Conventional Bare Stent Implantation in the "Real World". The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation. 2004; 109:190-195.
20. Douglas JS, Jr., Gruentzig AR, King SB, 3rd, Hollman J, Ischinger T, Meier B, et al. Percutaneous transluminal coronary angioplasty in patients with prior coronary bypass surgery. J Am Coll Cardiol 1983; 2:745-754.
21. Morrison DA, Sethi G, Sacks J, Henderson WG, Grover F, Sedlis S, et al. Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomised trial and registry experience with post-CABG patients. J Am Coll Cardiol 2002; 40:1951-1954.
22. Platko WP, Hollman J, Whitlow PL, Franco I. Percutaneous transluminal angioplasty of saphenous vein graft stenosis: long-term follow-up. J Am Coll Cardiol 1989; 14:1645-1650.
23. de Feyter PJ, van Suylen RJ, de Jaegere PP, Topol EJ, Serruys PW. Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. J Am Coll Cardiol 1993; 21:1539-1549.
24. Plokker HW, Meester BH, Serruys PW. The Dutch experience in percutaneous transluminal angioplasty of narrowed saphenous veins used for aortocoronary arterial bypass. Am J Cardiol 1991; 67:361-366.
25. Lowe HC, Oesterle SN, Khachigian LM. Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol 2002; 39:183-193.
26. Bhargava B, Karthikeyan G, Abizaid AS, Mehran R. New approaches to preventing restenosis. BMJ 2003; 327:274-279.
27. Saia FLP, Arampatzis C, Hoye A, McFadden E, Sianos G, Smits P, et al. Clinical and angiographic outcomes after over-dilatation of undersized sirolimus-eluting stents with largely oversized balloons. An observational study. Catheterization and Cardiovascular Interventions (In press).
28. de Feyter PJ, Kay P, Disco C, Serruys PW. Reference chart derived from post-stent-implantation intravascular ultrasound predictors of six-month expected restenosis on quantitative coronary angiography. Circulation 1999; 100:1777-1783.